BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 25942502)

  • 1. Somatostatin Analogs Treated Small Intestinal Neuroendocrine Tumor Patients Circulating MicroRNAs.
    Li SC; Khan M; Caplin M; Meyer T; Öberg K; Giandomenico V
    PLoS One; 2015; 10(5):e0125553. PubMed ID: 25942502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of miR-196a on gene regulation of neuroendocrine tumor cells.
    Li SC; Shi H; Khan M; Caplin M; Meyer T; Öberg K; Giandomenico V
    Mol Cell Endocrinol; 2015 Sep; 412():131-9. PubMed ID: 26052033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating Transcript Analysis (NETest) in GEP-NETs Treated With Somatostatin Analogs Defines Therapy.
    Ćwikła JB; Bodei L; Kolasinska-Ćwikła A; Sankowski A; Modlin IM; Kidd M
    J Clin Endocrinol Metab; 2015 Nov; 100(11):E1437-45. PubMed ID: 26348352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global microRNA profiling of well-differentiated small intestinal neuroendocrine tumors.
    Li SC; Essaghir A; Martijn C; Lloyd RV; Demoulin JB; Oberg K; Giandomenico V
    Mod Pathol; 2013 May; 26(5):685-96. PubMed ID: 23328977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of MicroRNA miR-7-5p Is a Potential Biomarker in Neuroendocrine Neoplasms of the Small Intestine.
    Heverhagen AE; Legrand N; Wagner V; Fendrich V; Bartsch DK; Slater EP
    Neuroendocrinology; 2018; 106(4):312-317. PubMed ID: 28848144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A plausible role for actin gamma smooth muscle 2 (ACTG2) in small intestinal neuroendocrine tumorigenesis.
    Edfeldt K; Hellman P; Westin G; Stalberg P
    BMC Endocr Disord; 2016 Apr; 16():19. PubMed ID: 27107594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between somatostatin analogues and diabetes mellitus in gastroenteropancreatic neuroendocrine tumor patients: A Surveillance, Epidemiology, and End Results-Medicare analysis of 5235 patients.
    Ni K; Yang JY; Baeg K; Leiter AC; Mhango G; Gallagher EJ; Wisnivesky JP; Kim MK
    Cancer Rep (Hoboken); 2021 Oct; 4(5):e1387. PubMed ID: 33835729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with somatostatin analogs induces differentially expressed let-7c-5p and mir-3137 in small intestine neuroendocrine tumors.
    Bösch F; Bazhin AV; Heublein S; Brüwer K; Knösel T; Reiter FP; Auernhammer CJ; Guba MO; Spitzweg C; Werner J; Angele MK
    BMC Cancer; 2019 Jun; 19(1):575. PubMed ID: 31196127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatostatin analogs in association with peptide receptor radionucleotide therapy in advanced well-differentiated NETs.
    Prinzi N; Raimondi A; Maccauro M; Milione M; Garanzini E; Torchio M; Corti F; Nichetti F; Lo Russo G; Giacomelli L; Mazzaferro V; Di Bartolomeo M; Seregni E; de Braud F; Pusceddu S
    Future Oncol; 2019 Sep; 15(26):3015-3024. PubMed ID: 31424273
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of controversial gastroenteropancreatic neuroendocrine tumour clinical situations with somatostatin analogues: results of a Delphi questionnaire panel from the NETPraxis program.
    Sevilla I; Segura Á; Capdevila J; López C; García-Carbonero R; Grande E;
    BMC Cancer; 2016 Nov; 16(1):858. PubMed ID: 27821081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatostatin analogs in pregnant patients with neuroendocrine tumor.
    Meoni G; Giommoni E; Petreni P; Pillozzi S; Mazzoni F; Pellegrini E; Brugia M; Lunghi A; Muto A; Antonuzzo L
    Anticancer Drugs; 2020 Nov; 31(10):1096-1098. PubMed ID: 32590392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression of somatostatin receptor 4 predicts clinical outcome of patients with metastatic neuroendocrine tumors treated with somatostatin analogs.
    Slaby O; Sachlova M; Bednarikova M; Fabian P; Svoboda M; Vytopilova S; Valik D; Vyzula R
    Cancer Biother Radiopharm; 2010 Apr; 25(2):237-43. PubMed ID: 20423238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic sequences in patients with grade 1-2 neuroendocrine tumors (NET): an observational multicenter study from the ELIOS group.
    Faggiano A; Di Maio S; Mocerino C; Ottaviano M; De Divitiis C; Guarnotta V; Dolce P; Modica R; Puliafito I; Tozzi L; Di Sarno A; Leo S; Riccardi F; Palmieri G; Tafuto S; Bianco A; Badalamenti G; Colao A;
    Endocrine; 2019 Nov; 66(2):417-424. PubMed ID: 30875056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global microRNA profiling of pancreatic neuroendocrine neoplasias.
    Thorns C; Schurmann C; Gebauer N; Wallaschofski H; Kümpers C; Bernard V; Feller AC; Keck T; Habermann JK; Begum N; Lehnert H; Brabant G
    Anticancer Res; 2014 May; 34(5):2249-54. PubMed ID: 24778027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic Mutations and Genetic Heterogeneity at the CDKN1B Locus in Small Intestinal Neuroendocrine Tumors.
    Crona J; Gustavsson T; Norlén O; Edfeldt K; Åkerström T; Westin G; Hellman P; Björklund P; Stålberg P
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1428-35. PubMed ID: 25586243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the WHO 2010 grading and AJCC/UICC staging systems in prognostic behavior of intestinal neuroendocrine tumors.
    Araujo PB; Cheng S; Mete O; Serra S; Morin E; Asa SL; Ezzat S
    PLoS One; 2013; 8(4):e61538. PubMed ID: 23620762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the BRAF V600E mutation in gastroenteropancreatic neuroendocrine tumors.
    Park C; Ha SY; Kim ST; Kim HC; Heo JS; Park YS; Lauwers G; Lee J; Kim KM
    Oncotarget; 2016 Jan; 7(4):4024-35. PubMed ID: 26684240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient reported symptoms, coping and quality of life during somatostatin analogue treatment for metastatic small- intestinal neuroendocrine tumours.
    Sorbye H; Meyer LS; Mordal KE; Myhre S; Thiis-Evensen E
    Health Qual Life Outcomes; 2020 Jun; 18(1):188. PubMed ID: 32546236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in small bowel neuroendocrine neoplasia.
    Banck MS; Beutler AS
    Curr Opin Gastroenterol; 2014 Mar; 30(2):163-7. PubMed ID: 24441281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer.
    Liu Y; Zhang G; Li H; Han L; Fu A; Zhang N; Zheng Y
    Biomed Pharmacother; 2015 Oct; 75():185-90. PubMed ID: 26337230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.